Drugs / NVP-1203
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02289274 | Nov → Dec 2019 | — | NVP Healthcare | Withdrawn | No outcome recorded |
| Phase 1 | NCT02289404 | Jan 2019 | — | NVP Healthcare | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03341832 | Jan 2018 → Jan 2019 | — | NVP Healthcare | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04082975 | Jan 2020 → May 2021 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04082975 ↗ |
| Route | Oral | “Oral” NCT02289404 ↗ |